Why did Trump double steel and aluminum tariffs?
How are tariffs impacting US retailers’ profits?
What caused $14B in EV and renewable projects cancellation?
Why is JPMorgan dimon warning about bond market cracks?
How did Tesla's robotaxi rollout alarm the public?
Why is the EU threatening countermeasures after US tariffs?
What’s behind Meta’s plan to replace humans with AI?
Intellia filing spurs safety concerns over CRISPR drug
biopharmadive.com/news/intellia-crispr-liver-enzyme-adverse-event-ttr-cardiomyopathy/749231
Dive Brief:
- Intellia Therapeutics shares dropped 25% early Thursday after the gene-editing company disclosed that one patient in an ongoing Phase 3 trial had signs of liver stress.
- Lab tests showed the patient had grade 4 liver transaminase elevations that “appear to be resolving”…
This story appeared on biopharmadive.com, 2025-05-30 09:18:44.472000.